16 results
·
24ms
·
Sources: EU EUDAMED, US FDA
Filters
Regulation: Us FDA
×
geko T-2 and geko T-3 Neuromuscular Stimulators
FDA 510(k)
FDA Class 2
·Physical Medicine
Orthos
FDA UDI
ORMCO CORPORATION·00889989029932·ORTHOS CM SST ARCH 021X025 LOSM PK10
APEX Knee System
FDA UDI
Omni Life Science, Inc.·00841690198918·AK3 Congruent Insert Trial Size 1, 13mm
NOVO Surgial
FDA UDI
NOVO SURGICAL, INC.·00842331184093·Jeweler's Bipolar Forceps, 0.4 mm tip, 4" (10.0...
GUARDIAN II NC HEMOSTASIS VALVE
FDA 510(k)
FDA Class 2
·Cardiovascular
MAXIMA V, THREE WHEEL SCOOTER, MODEL SC900V MAXIMA V, FOUR WHEEL SCOOTER, MODEL SC940V
FDA 510(k)
FDA Class 2
·Physical Medicine
MOSAIC AORTIC BIOPROSTHETIC HEART VALVE
FDA Adverse Event
Death
·MEDTRONIC HEART VALVES DIVISION·Product code DYE·December 17, 2020
OBTRYX SYSTEM
FDA Adverse Event
Injury
·BOSTON SCIENTIFIC - MARLBOROUGH·Product code FTL·June 26, 2013
AKREOS AO MICRO INCISION LENS
FDA Adverse Event
Injury
·BAUSCH + LOMB·Product code HQL·July 29, 2011
J-VAC RESERVOIR
FDA Adverse Event
Malfunction
·ETHICON, INC.·Product code GCY·September 26, 2008
MOSAIC AORTIC BIOPROSTHETIC HEART VALVE
FDA Adverse Event
Injury
·MEDTRONIC HEART VALVES DIVISION·Product code DYE·December 17, 2020
GELFOAM
FDA Adverse Event
Injury
·PFIZER, INC. (DEVICE)·Product code LMF·June 3, 2019
SINGLE USE GUIDWIRE
FDA Adverse Event
Malfunction
·TERUMO CORPORATION, ASHITAKA·Product code OCY·April 21, 2020
ARCHITECT MAGNESIUM, (a) REF 7D70-21, (b) 7D70-31 The Magnesium assay is used for the quantitation of magnesium in human serum, plasma, or urine.
FDA Enforcement
Class II
·Terminated·Abbott Laboratories, Inc·March 13, 2019
SCENARIA View: Software Version V1.08, V1.09B, V1.09C, V1.09D, V1.0B, V1.0C
FDA Enforcement
Class II
·Ongoing·FUJIFILM Healthcare Americas Corporation·September 21, 2022
cobas 6000 Modular Series system; Part Numbers: 1. 04745914001 cobas c 501 module; 2. 05036453001 cobas 6000 UL c 501 + Core Fix configuration; 3. 05036453692 - cobas 6000 UL + CORE CU; and 4. 05860636001 cobas 6000 c 501 (UL) V
FDA Enforcement
Class II
·Terminated·Roche Diagnostics Corporation·March 14, 2018